Drug Trial Radar · NCT07850609
A Clinical Study of Alimatravir (MK-8527) in Transgender (Trans) and Gender Diverse Individuals on Gender-affirming Hormone Therapy and at Low Likelihood of Human Immunodeficiency Virus (HIV)-1 Exposure (MK-8527-018)
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
80
Planned (sponsor's estimate)
Start
Oct 27, 2026
Primary completion
Dec 2, 2027
Study completion Dec 2, 2027
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Sep 30, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this study is to learn about the safety of alimatravir (MK-8527) in transgender and gender-diverse people and if they tolerate it.
Conditions
- HIV
Interventions
AlimatravirDrug
11 mg tablets taken orally once monthly (qm) for a total of 3 doses
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Who Experience an Adverse Event (AE)Time frame: Up to approximately 4 months
- Number of Participants Who Discontinue Study Treatment Due to an AETime frame: Up to approximately 2 months
Locations
7 sites in 2 countries. Site status is shown where the registry gives one.
Bridge HIV - San Francisco Department of Public Health ( Site 0002)
San Francisco, California · Recruiting
Whitman-Walker Institute ( Site 0008)
Washington D.C., District of Columbia · Recruiting
Fenway Health ( Site 0004)
Boston, Massachusetts · Recruiting
Mazzoni Center ( Site 0010)
Philadelphia, Pennsylvania · Recruiting
Maple Leaf Research ( Site 0102)
Toronto, Ontario, Canada · Recruiting
Clinique de médecine Urbaine du Quartier Latin ( Site 0101)
Montreal, Quebec, Canada · Recruiting
Gestion clinique médicale l'Actuel ( Site 0100)
Montreal, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.